Biotech Values

[biomaven0]

>>Non-responders died quickly.

Right. Just to expand on that, OS is looking at the drug arm as a whole; duration of response is looking only at the subgroup where there was a CR or PR.

So what these results are saying is that usually the drug does not work, but when it does work it works fairly decently.

I've always worried that blocking MET is potentially double-edged - in some circumstances it might actually be bad.

Peter